Antimicrobial stewardship changes: preparing your business
Changes affecting antimicrobial stewardship in Great Britain under the UK-EU Sanitary and Phytosanitary (SPS) Agreement.
Who this applies to
This guidance applies to:
-
veterinary professionals and any others involved in the prescription or application of antimicrobials to animals
-
farmers and other keepers of food-producing animals
UK-EU SPS Agreement changes
As part of the UK-EU Sanitary and Phytosanitary (SPS) Agreement, Great Britain (GB) will apply EU rules on certain aspects of antimicrobial stewardship. The changes will help maintain protections for public health, animal health and food safety while making trade between GB and the EU easier. These benefits will be extended for movements from GB to Northern Ireland through the Agreement’s interplay with the Windsor Framework.
The date of application of the SPS Agreement is 1 March 2028. This is the date from which the new requirements will apply. The VMD will continue to publish technical guidance and provide stakeholder engagement opportunities between now and the application date.
Continue to follow current requirements until the changes take effect and monitor GOV.UK for further updates. For more information about changes in the veterinary sector, see Veterinary Sector: preparing your business.
For general information about the SPS Agreement, see SPS agreement: preparing your business.
The wider veterinary medicines authorisation regime is not in scope of the SPS Agreement.
What the SPS Agreement means for antimicrobial stewardship
The main areas where there will be changes because of the SPS Agreement are listed below:
-
Restrictions for prophylactic use
-
Restrictions for metaphylactic use
-
Antimicrobials reserved for human use
Restrictions for prophylactic use
From the application date, the following restrictions will apply:
-
Antimicrobial medicinal products shall not be used for prophylaxis (preventive treatment before disease occurs) other than in exceptional cases. Use must be limited to administration to an individual animal or a restricted number of animals through individual administration when the risk of an infection or of an infectious disease is very high and the consequences are likely to be severe. In such cases, the use of antibiotic medicinal products for prophylaxis shall be limited to the administration to an individual animal.
-
Medicated feed containing an antibiotic veterinary medicinal product cannot be prescribed for prophylactic use.
Currently, in exceptional cases, veterinary surgeons in Great Britain may prescribe antibiotics as prophylactic treatments to groups of animals, provided that they record the rationale and carry out a management review at the time of administration (or as soon as reasonably practicable afterwards). This is in order to identify factors and implement measures for the purpose of eliminating the need for any future such administration.
From the application date of the SPS Agreement this will change, and veterinary surgeons will no longer be permitted to do this.
For the purposes of this guidance, group administration means giving antibiotics to more than one animal at the same time through feed, water, milk or milk replacer, or liquid feed.
A restricted number of animals must be treated individually, for example by injection or intramammary administration, and one animal at a time.
Restrictions for metaphylactic use
From the application date, the following restrictions will apply:
- Antimicrobial medicinal products shall be used for metaphylaxis (treating a group of animals when some are ill and others are at high risk) only when the risk of spread of an infection or of an infectious disease in the group of animals is high and where no other appropriate alternatives are available.
In GB, we do not currently have any specific restrictions on metaphylactic use beyond those set out for antimicrobials in general, so veterinary professionals will need to take into account this additional restriction.
Appropriate alternatives will depend on the specific disease and circumstances. They may include separation and individual treatment of affected animals, vaccination, changes to mixing or stocking, biosecurity, environmental or husbandry changes and/or the use of a non-antimicrobial treatment where clinically appropriate.
Antimicrobials reserved for human use
Medicinal products containing antimicrobials designated as reserved for treatment of certain infections in humans must not be used in animals, including under the prescribing cascade. The designated list is contained in the Annex to Commission Implementing Regulation (EU) 2022/1255.
Previously, the use of these antimicrobials wasn’t allowed for use in food producing animals but were permitted for use under the prescribing cascade in animals that would not enter the food chain (such as companion animals and some equines). One example of this is the use of amantadine (an antiviral drug) under the prescribing cascade for the management of chronic pain in cats and dogs.
From the application date, the listed antimicrobials must not be used in any animal, whether food-producing or non-food-producing, including under the prescribing cascade.
Contact
For questions about veterinary medicines and the changes under the SPS Agreement, contact the Veterinary Medicines Directorate. You can also sign up for VMD email alerts.